scholarly journals The World Federation of Scientific Workers

Nature ◽  
1964 ◽  
Vol 204 (4955) ◽  
pp. 233-233
Keyword(s):  

Vox Sanguinis ◽  
1991 ◽  
Vol 61 (3) ◽  
pp. 221-224
Author(s):  
C.K. Kasper ◽  
P.M. Mannucci ◽  
V. Bulyzhenkov ◽  
D.B. Brettler ◽  
A. Chuansumrit ◽  
...  




2021 ◽  
pp. 135245852110302
Author(s):  
Joanna Laurson-Doube ◽  
Nick Rijke ◽  
Anne Helme ◽  
Peer Baneke ◽  
Brenda Banwell ◽  
...  

Background: Off-label disease-modifying therapies (DMTs) for multiple sclerosis (MS) are used in at least 89 countries. There is a need for structured and transparent evidence-based guidelines to support clinical decision-making, pharmaceutical policies and reimbursement decisions for off-label DMTs. Objectives/Results: The authors put forward general principles for the ethical use of off-label DMTs for treating MS and a process to assess existing evidence and develop recommendations for their use. Conclusion: The principles and process are endorsed by the World Federation of Neurology (WFN), American Academy of Neurology (AAN), European Academy of Neurology (EAN), Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Middle-East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) and Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), and we have regularly consulted with the Brain Health Unit, Mental Health and Substance Use Department at the World Health Organization (WHO).





2009 ◽  
Vol 33 (1) ◽  
pp. 68-78
Author(s):  
Will Longstreth ◽  
Than Ton ◽  
Amethyst Leimpeter ◽  
Stephen K. Van Den Eeden




1985 ◽  
Vol 23 (3) ◽  
pp. 330-332
Author(s):  
Willem Luyendijk ◽  
H.Alphons D. Walder
Keyword(s):  


Sign in / Sign up

Export Citation Format

Share Document